Previous work has shown that antibiotic-treated cells experience increased flux through metabolic pathways that lead to reactive metabolic by-products irrespective of the primary antibiotic-binding target, and these reactive metabolic by-products have been evidenced to contribute to antibiotic lethality 2,3,4,5,6,7,8,9,10,11,12,13,29
While compounded medications are not FDA-approved like brand names, 503A compounded GLP-1s have demonstrated equivalent efficacy and safety profiles in clinical use
doi: 10.1016/j.hrthm.2020.05.001 167 SivaprakasamS.BhutiaY
The expression of HO-1, a cytoprotective enzyme critical for heme protein metabolism and ferroptosis, was also highly expressed in iron-accumulating renal cells and in mice with hypertensive nephropathy [257, 260, 261]